The effect of NOD2 activation on TLR2-mediated cytokine responses is dependent on activation dose and NOD2 genotype

Genes and Immunity

Volumn 9, Issue 3, 2008, Pages 274-278

  Borm, M E A ^a   van Bodegraven, A A ^a   Mulder, C J J ^a   Kraal, G ^a   Bouma, G ^a  

^a VU UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

CASPASE RECRUITMENT DOMAIN PROTEIN 15; MURAMYL DIPEPTIDE; TOLL LIKE RECEPTOR 2; TUMOR NECROSIS FACTOR ALPHA;

ARTICLE; BACTERIAL IMMUNITY; CELL STIMULATION; CLINICAL ARTICLE; CONCENTRATION RESPONSE; CONTROLLED STUDY; CROHN DISEASE; CYTOKINE PRODUCTION; DOWN REGULATION; HUMAN; HUMAN CELL; IMMUNE RESPONSE; MONOCYTE; PRIORITY JOURNAL; PROTEIN PROTEIN INTERACTION; REGULATORY MECHANISM;

ACETYLMURAMYL-ALANYL-ISOGLUTAMINE; CROHN DISEASE; GENE EXPRESSION REGULATION; GENOTYPE; HUMANS; MONOCYTES; MUTATION; NOD2 SIGNALING ADAPTOR PROTEIN; TOLL-LIKE RECEPTOR 2;

BACTERIA (MICROORGANISMS); MUS;

EID: 42549167131     PISSN: 14664879     EISSN: 14765470     Source Type: Journal    
DOI: 10.1038/gene.2008.9     Document Type: Article

References (17)

1. Ogura Y, Bonen DK, Inohara N, Nicolae DL, Chen FF, Ramos R et al. A frameshift mutation in NOD2 associated with susceptibility to Crohn's disease. Nature 2001; 411: 603-606.
2. Hugot JP, Chamaillard M, Zouali H, Lesage S, Cezard JP, Belaiche J et al. Association of NOD2 leucine-rich repeat variants with susceptibility to Crohn's disease. Nature 2001; 411: 599-603.
3. Inohara N, Chamaillard M, McDonald C, Nunez G. NOD-LRR proteins: Role in host-microbial interactions and inflammatory disease. Annu Rev Biochem 2005; 74: 355-383.
4. Bouma G, Strober W. The immunological and genetic basis of inflammatory bowel disease. Nat Rev Immunol 2003; 3: 521-533.
5. Inohara N, Ogura Y, Fontalba A, Gutierrez O, Pons F, Crespo J et al Host recognition of bacterial muramyl dipeptide mediated through NOD2: Implications for Crohn's disease. J Biol Chem 2003; 278 5509-5512.
6. Girardin SE, Boneca IG, Viala J, Chamaillard M, Labigne A, Thomas G et al. NOD2 is a general sensor of peptidoglycan through muramyl dipeptide (MDP) detection. J Biol Chem 2003; 278: 8869-8872.
7. Watanabe T, Kitani A, Murray PJ, Strober W. NOD2 is a negative regulator of Toll-like receptor 2-mediated T helper type 1 responses. Nat Immunol 2004; 5: 800-808.
8. Watanabe T, Kitani A; Murray PJ, Wakatsuki Y, Fuss IJ, Strober W. Nucleotide binding oligomerization domain 2 deficiency leads to dysregulated TLR2 signaling and induction of antigen-specific colitis. Immunity 2006; 25: 473-485.
9. van Heel DA, Ghosh S, Hunt KA, Mathew CG, Forbes A, Jewell DP et al Synergy between TLR9 and NOD2 innate immune responses is lost in genetic Crohn's disease. Gut 2005; 54: 1553-1557.
10. Netea MG, Ferwerda G, de Jong DJ, Jansen T, Jacobs L, Kramer M et al Nucleotide-binding oligomerization domain-2 modulates specific TLR pathways for the induction of cytokine release. J Immunol 2005; 174: 6518-6523.
11. Bonen DK, Ogura Y, Nicolae DL, Inohara N, Saab L, Tanabe T et al. Crohn's disease-associated NOD2 variants share a signaling defect in response to lipopolysaccharide and peptidoglycan. Gastroenterology 2003; 124: 140-146.
12. van Heel DA, Ghosh S, Butler M, Hunt KA, Lundberg AM, Ahmad T et al Muramyl dipeptide and toll-like receptor sensitivity in NOD2-associated Crohn's disease. Lancet 2005; 365: 1794-1796.
13. Monteleone G, Biancone L, Marasco R, Morrone G, Marasco O, Luzza F et al. Interleukin 12 is expressed and actively released by Crohn's disease intestinal lamina propria mononuclear cells. Gastroenterology 1997; 112: 1169-1178.
14. Fuss IJ, Neurath M, Boirivant M, Klein JS, de la Motte C, Strong SA et al. Disparate CD4+ lamina propria (LP) lymphokine secretion profiles in inflammatory bowel disease. Crohn's disease LP cells manifest increased secretion of IFN-gamma, whereas ulcerative colitis LP cells manifest increased secretion of IL-5. J Immunol 1996; 157 1261-1270.
15. Lala S, Ogura Y, Osborne C, Hor SY, Bromfield A, Davies S et al. Crohn's disease and the NOD2 gene: A role for paneth cells. Gastroenterology 2003; 125: 47-57.
16. Li J, Moran T, Swanson E, Julian C, Harris J, Bonen DK et al. Regulation of IL-8 and IL-1beta expression in Crohn's disease associated NOD2/CARD15 mutations, Hum Mol Genet 2004; 13: 1715-1725.
17. Gutierrez O, Pipaon C, Inohara N, Fontalba A, Ogura Y, Prosper F et al. Induction of NOD2 in myelomonocytic and intestinal epithelial cells via nuclear factor-kB. J Biol Chem 2002; 277: 41701-41705.